Pendium

Step 1 of 9

Bioderma is a powerhouse in AI skincare recommendations, owning the sensitive skin and micellar categories.

Here is how you're performing against the major clinical incumbents and where the next growth openings are.

Bioderma's baseline score
76/100
Good

Bioderma has exceptional AI visibility, particularly in the micellar water and sensitive skin segments. While it is a category leader, there is significant room to capture more 'eczema' and 'acne' mentions where US-centric competitors currently have a slight edge in AI Overviews.

What we see
  • Bioderma dominates 'best micellar water' prompts across all platforms due to decades of editorial coverage.
  • CeraVe and La Roche-Posay currently lead in AI mentions for general 'dermatologist recommended' body care prompts in the US market.
  • Gemini and AI Overviews frequently surface Bioderma in the context of 'French Pharmacy' hauls and YouTube creator content.
  • Claude is more likely to name Bioderma when the prompt specifies 'sensitive skin' rather than general hydration.
  • There is a visibility gap in 'acne treatment' prompts where competitors like La Roche-Posay (Effaclar) are mentioned more frequently than Sébium.
Business goals Bioderma is likely trying to hit
  • Position Atoderm as the primary recommendation for US eczema sufferers
  • Maintain the Sensibio micellar water's status as the global gold standard
  • Educate consumers on the NAOS ecobiology philosophy to differentiate from generic clinical brands
  • Drive high-intent traffic to US retail partners like Walgreens and Target